JS
NTUS

Jeffrey Smith’s Natus Medical Inc NTUS Stock Holding History

Jeffrey Smith’s Portfolio NTUS Stock Details NTUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-563,329
Closed -$14.5M – 21
2019
Q2 		$14.5M Sell
563,329
-567,862
-50% -$14.5M 0.44% 16
2019
Q1 		$28.7M Buy
+1,131,191
New +$33.8M 0.7% 18

Other funds holding NTUS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CRM
Cramer Rosenthal McGlynn Stamford, Connecticut $1.98B AUM 60.71% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Jeffrey Smith's NTUS Position: Q3 2019 in Review

Jeffrey Smith sold out of Natus Medical Inc (NTUS) in Q3 2019, closing a stake of 563,329 shares — an estimated $14.5M sold.

Jeffrey Smith first reported a position in NTUS in Q1 2019 and held it in 2 quarters. The position peaked at $28.7M in Q1 2019. 168 funds tracked by Wall St. Rank hold NTUS as of Q3 2019.

  • Jeffrey Smith reported no remaining Natus Medical Inc position as of Q3 2019 after selling out during the quarter.
  • Jeffrey Smith sold 563,329 Natus Medical Inc shares in Q3 2019, an estimated $14.5M.
  • Jeffrey Smith first reported a position in Natus Medical Inc in Q1 2019 and held it in 2 quarters.
  • Jeffrey Smith's Natus Medical Inc position peaked at $28.7M in Q1 2019.
  • 168 funds tracked by Wall St. Rank held Natus Medical Inc as of Q3 2019.

Based on Starboard Value's 13F filing for Q3 2019, filed 14 Nov 2019.